Skip to main content

Advertisement

Table 1 Patient characteristics at diagnosis

From: Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years

Age at diagnosis Years  
Mean (range) 69.2 (45 – 88)  
Age at diagnosis Number of Patients Percent of Patients
45–49 1 0.3
50–54 7 2.3
55–59 23 7.6
60–64 35 11.5
65–70 54 17.8
70–74 80 26.3
75–79 54 17.8
80–84 36 11.8
85-88 14 4.6
PSA level at diagnosis ng/mL  
Mean (range) 6.08 (0.7 to 27.7)  
Median 5.8  
PSA level at diagnosis Number of Patients Percent of Patients
<4 ng/mL 59 19.4
4–10 ng/mL 203 66.8
>10–20 ng/mL 40 13.2
>20 ng/mL 2 0.7
Clinical Stage Number of Patients Percent of Patients
T1cN0M0 280 92.1
T2aN0M0 24 7.9
Gleason Score Number of Patients Percent of Patients
= 6 222 73
=7 70 23
> 8 12 4
Hormone Treatment Number of Patients Percent of Patients
No 247 81.3
Yes 57 18.8
Risk Assessment: Criteria Number of Patients Percent of Patients
Low Risk: Gleason Score ≤ 6 and PSA ≤ 10 ng/ml. 211 69.4
Intermediate Risk: Gleason = 7 or PSA > 10 and PSA < 20 81 26.6
High Risk: Gleason ≥ 8 or PSA > 20 12 0.7